Trial intelligence / Profile preview

Azithromycin vs Erythromycin in PPROM

NCT01556334Phase 3Withdrawn

Sponsor
Indiana University
Start
Apr 2010
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of azithromycin in preterm premature rupture of membranes (pPROM), sponsored by Indiana University. Planned start Apr 2010; status: withdrawn.

02

Drugs

azithromycin
03

Conditions

preterm premature rupture of membranes (pPROM)

Beyond the preview

Go deeper on NCT01556334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01556334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call